Skip to main content
logo
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
83.99
+3.55 (4.41%)
At close: Jul 2, 2026, 4:00 PM EDT
83.90
-0.09 (-0.11%)
After-hours: Jul 2, 2026, 7:46 PM EDT

Arrowhead Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had revenue of $73.74M in the quarter ending March 31, 2026, a decrease of -86.41%. This brings the company's revenue in the last twelve months to $622.01M, up 14.09% year-over-year. In the fiscal year ending September 30, 2025, Arrowhead Pharmaceuticals had annual revenue of $829.45M with 23,258.15% growth.

Revenue (ttm)
$622.01M
Revenue Growth
+14.09%
P/S Ratio
19.02
Revenue / Employee
$874,837
Employees
711
Market Cap
11.83B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2025829.45M825.90M23,258.15%
Sep 30, 20243.55M-237.18M-98.52%
Sep 30, 2023240.74M-2.50M-1.03%
Sep 30, 2022243.23M104.94M75.89%
Sep 30, 2021138.29M50.30M57.16%
Sep 30, 202087.99M-80.80M-47.87%
Sep 30, 2019168.80M152.65M945.68%
Sep 30, 201816.14M-15.27M-48.60%
Sep 30, 201731.41M31.25M19,736.48%
Sep 30, 2016158.33K-223.67K-58.55%
Sep 30, 2015382.00K207.00K118.29%
Sep 30, 2014175.00K-115.27K-39.71%
Sep 30, 2013290.27K143.39K97.63%
Sep 30, 2012146.88K-149.26K-50.40%
Sep 30, 2011296.14K--
Sep 30, 2010---
Sep 30, 20093.76M2.45M188.38%
Sep 30, 20081.30M95.18K7.88%
Sep 30, 20071.21M746.74K161.88%
Sep 30, 2006461.28K-129.40K-21.91%
Sep 30, 2005590.68K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioMarin Pharmaceutical3.24B
Exelixis2.38B
Bio-Techne1.21B
Madrigal Pharmaceuticals1.13B
Ionis Pharmaceuticals1.06B
Axsome Therapeutics708.24M
Krystal Biotech417.30M
Cytokinetics105.82M
Revenue Rankings

ARWR News

More News